Effects of major ozonated autohemotherapy in the treatment of dry age related macular degeneration: a randomized controlled clinical study
This randomized controlled trial evaluated the efficacy of major ozonated autohemotherapy (O3-AHT) in treating dry age-related macular degeneration (AMD). The study showed that O3-AHT significantly improved visual acuity, with 25% of patients in the treatment group gaining at least one line of vision after 12 months, compared to none in
June 26, 2025
No Comments